Navigation Links
Isis Reports Financial Results and Highlights for Third Quarter 2011
Date:11/7/2011

CARLSBAD, Calif., Nov. 7, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its financial results for the quarter ended September 30, 2011.  The Company finished the third quarter of 2011 with a pro forma net operating loss (NOL) of $20.0 million and $44.9 million for the three and nine months ended September 30, 2011, respectively, compared to a pro forma NOL of $6.0 million and $23.1 million for the same periods in 2010.  The Company finished the third quarter of 2011 with nearly $365 million in cash.  

"Our most notable success this year has been the submission of the Kynamro™ marketing authorization application to the European Medicines Agency.  With this submission, we are one step closer to commercializing Kynamro for patients who are at great risk of dying from their cardiovascular disease.  Genzyme remains on track to submit the U.S. application for marketing approval in the fourth quarter and is actively preparing to launch Kynamro next year in the U.S. and Europe.  Kynamro represents the first major commercial opportunity for Isis, and we are looking forward to its potential launch next year," said B. Lynne Parshall, J.D., Chief Operating Officer, Chief Financial Officer and Secretary of Isis.  "Together with Genzyme, we are initiating our next Kynamro study, FOCUS FH, this year, which is intended to support an expansion of the market for Kynamro for severe forms of hypercholesterolemia.  We and Genzyme are committed to continuing investments in this novel medicine to make it available to as many patients as appropriate to treat their severe and fatal cardiovascular disease."

Upcoming Key Milestones

  • File for marketing approval for Kynamro™ (mipomersen) in the United States in the fourth quarter of 2011 for patients with homozygous Familial Hypercholesterolemia (FH
    '/>"/>

  • SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
    2. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
    3. Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
    4. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
    5. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
    6. Cambrex Reports Third Quarter 2011 Results
    7. Dyadic International Reports 2011 Third Quarter Financial Results
    8. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
    9. Mettler-Toledo International Inc. Reports Third Quarter 2011 Results
    10. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
    11. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
    (Date:8/21/2014)... 2014  ACI Clinical ( www.aciclinical.com ) announces ... Committees. Using this solution, trial sponsors ... standard costs and receive the same expertise that ... services. Leveraging a decade of DMC ... development, statistical programming and meeting facilitation), ACI analyzed ...
    (Date:8/21/2014)... FRANCISCO , Aug. 21, 2014 /PRNewswire/ ... Food and Drug Administration (FDA) has granted ... detect atrial fibrillation (AFib), the most common ... process (algorithm) instantly detects if patients are ... taken on the mobile phone based AliveCor® ...
    Breaking Medicine Technology:ScriptPro Achieves HITRUST Certification 2ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
    ... Recent biopharmaceutical product launches have produced both noteworthy failures ... organizations are rethinking the factors that play the biggest ... wide-ranging research project that explores the pivotal success factors ... LLC established a critical core set of factors that ...
    ... DIEGO, Feb. 17, 2011 Conatus Pharmaceuticals Inc. announced ... multi-center Phase 2b clinical trial evaluating CTS-1027 in combination ... treatment experienced, hepatitis C (HCV) null responder patient population. ... will be assessed after up to 48 weeks of ...
    Cached Medicine Technology:Success Factors and Failure Points in Biopharmaceutical Product Launches 2Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV) 2Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV) 3
    (Date:8/22/2014)... time provides an opportunity for parents to develop an ... expert suggests. "Forget New Year,s resolutions; the start ... start of a new fitness and exercise program for ... University of the Sciences in Philadelphia, said in a ... to build up, "it,s important for mom and dad ...
    (Date:8/22/2014)... RI Newport Hospital has again attained the ... Credentialing Center,s (ANCC) Magnet Recognition Program. Considered the ... credentialing program recognizes nursing excellence and professionalism. It ... care. The unanimous decision to redesignate Newport Hospital ... rigorous national standards of nursing practice. , "It ...
    (Date:8/22/2014)... News) -- Many children get anxious or afraid when ... a number of ways that parents can make these ... The first step is to explain to children in ... health, said Rita John, director of the pediatric primary ... Nursing in New York City. "Children need to ...
    (Date:8/22/2014)... 22, 2014 Women with severe disabilities and multiple ... than women with no disabilities or no chronic conditions, ... screened less often than women with moderate disabilities or ... Sara Guilcher, an affiliate scientist with the Li Ka ... Guilcher said women with disabilities often have other measures ...
    (Date:8/22/2014)... Pirate Jonny's Caribbean BBQ Rubs, Seasonings ... recipe cards, fun t-shirts, and caps for consumers to ... Florida, Pirate Jonny, aka, Jonathan Toner, founder, decided that ... three recipes featuring different flavors of the Caribbean, in ... The recipe cards will feature "easy to make" ...
    Breaking Medicine News(10 mins):Health News:With Kids in School, Parents Can Work Out 2Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:Women with severe, chronic health issues are screened for breast cancer less often 2Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2
    ... that the brain is always alert even if there is ... they are listening out for a sound. ,Pierre ... national research institute. He studied the brain activity of 11patients ... Imaging. // It showed that they were actually listening ...
    ... leg pain and very pale skin can all be early ... ,Thousand’s of children's lives will be saved ... for parents, which could speed diagnosis and treatment. ... their child having a headache, stiff neck, sensitivity to light ...
    ... Professor Stuart J. Connolly and his team from McMaster ... JAMA that a combination of Antiarrhythmic drugs such as ... found to reduce the painful shocks in ventricular arrhythmia ... high voltage shocks which are used to treat fatal ...
    ... is lot of relaxation in weight reduction programs. This however cannot ... is to listen to one’s inner voice and constantly work towards ... voice starts piping up as you lie on the couch. "Go ... those potato chips," it urges., ,The voice is that ...
    ... led to researchers warning British tourists to keep away from ... into Britain. Despite these warnings of a possible spread of ... Association of British Travel Agents had reported that the tourist ... be not afraid of bird flu threat. The tour promoters ...
    ... shown that tomato juice prevented emphysema in mice exposed to ... disease. // ,The lung protective effect was attributed ... to be the first to link tomato consumption to emphysema ... 'We can't simply accept that these results go beyond the ...
    Cached Medicine News:Health News:New warning signs for child meningitis 2Health News:Being Active In Winter Despite That Inner Urge 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: